v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (33,253) $ (27,042)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 4,908 2,765
Depreciation and amortization 2,917 1,318
Amortization of deferred costs 1,246 1,070
Non-cash operating lease expense 3,857 811
Changes in operating assets and liabilities:    
Accounts receivable (3,325) (1,201)
Inventories (1,934) 13
Deferred costs (467) (1,692)
Prepaid expenses and other current assets (654) 101
Other assets (6) (9)
Accounts payable 3,287 1,226
Accrued and other current liabilities (1,383) 2,308
Deferred revenue (1,617) 306
Operating lease liabilities (843) (727)
Net cash used in operating activities (27,267) (20,753)
Cash flows from investing activities:    
Purchase of property, plant and equipment (6,834) (11,799)
Net cash used in investing activities (6,834) (11,799)
Cash flows from financing activities:    
Proceeds from issuance of common stock upon exercise of stock warrants 14,384 1
Payment of equity financing costs (756) (406)
Proceeds from exercise of stock options 96 115
Net cash provided by financing activities 24,585 16,252
Net decrease in cash, cash equivalents and restricted cash equivalents (9,516) (16,300)
Cash, cash equivalents and restricted cash equivalents, beginning of period 45,817 69,752
Cash, cash equivalents and restricted cash equivalents, end of period 36,301 53,452
Reconciliation of cash, cash equivalents and restricted cash equivalents shown on the condensed consolidated balance sheets:    
Cash and cash equivalents 35,045 53,396
Restricted cash equivalents included in other assets 1,256 56
Total cash, cash equivalents and restricted cash equivalents 36,301 53,452
Supplemental non-cash investing and financing activities:    
Unpaid purchases of property, plant and equipment 155 2,039
Increase in fair value of modified stock warrants 727 0
Unpaid financing costs from the issuance of shares of common stock 0 263
At Market Issuance Sales Agreement    
Cash flows from financing activities:    
Proceeds from issuance of common stock 10,861 0
Stock Purchase Agreement    
Cash flows from financing activities:    
Proceeds from issuance of common stock $ 0 $ 16,542

Source

PDF HTML
ZIP XLS XBRL